Related by context. All words. (Click for frequent words.) 68 CI -#.# 67 -#.# ± [002] 67 % Confidence Interval 66 lispro 65 mmol l 65 -#.# mg dL [002] 65 #.#mmol L [002] 65 -#.# log# 64 -#.# mg dL [001] 64 lumbar spine BMD 64 #.#/#.# mm Hg [003] 63 ALT elevation 63 detemir 63 μg d 63 HOMA IR 63 p ≤ 63 atorvastatin #mg 63 mg orally 63 nmol liter 62 HbA 1c levels 62 P ≤ 62 μg kg 62 #.#/#.# mmHg [001] 62 mmHg p = 62 #.#mg/dL 62 p = .# [002] 61 TC HDL 61 ß = 61 baseline HbA1c 61 #μg [001] 61 r2 = 61 adjunctive placebo 61 mg TID 61 uM 61 mL/min/#.# m 2 61 AUC0 61 PaO 2 61 ATV RTV 61 ìg 61 log# copies mL 61 p = NS 60 alanine aminotransferase 60 Hb A1C 60 lumbar spine bone 60 mEq 60 CI -#.# -#.# 60 aspartate aminotransferase 60 deoxy 60 fasting plasma glucose 60 μg mL 60 BENICAR HCT 60 hemoglobin A1c HbA1c 60 #mg/dL [002] 60 confidence interval #.#-#.# 60 mg qd 60 apolipoprotein B 60 -#.# ± [001] 60 leukocyte count 59 lopinavir r arm 59 NPH insulin 59 Xalatan R 59 serum urate 59 HBeAg seroconversion 59 glulisine 59 LPV r 59 alanine aminotransferase ALT 59 glycated hemoglobin levels 59 HbA 1c 59 HbA1C 59 microg 59 insulin detemir 59 mL kg 59 creatinine ratio 59 log# IU mL 59 #.#mmol L [001] 59 regression coefficient 59 MADRS score 59 ug kg 59 μmol L 59 #OHD 59 sodium excretion 59 serum potassium 59 biphasic insulin aspart 59 DJI #.# 59 femoral neck BMD 59 HbA1c levels 59 oral allopurinol 58 mIU ml 58 mmol L. 58 mmHg diastolic 58 glimepiride 58 fluticasone salmeterol 58 fasting plasma 58 fasting triglycerides 58 abacavir lamivudine 58 placebo p = 58 lowest tertile 58 ml kg 58 serum magnesium 58 TPV r 58 mmol 58 unfractionated heparin UFH 58 triiodothyronine 58 mmol liter 58 nondiabetic patients 58 Cmax 58 baseline FEV 58 rizatriptan 58 Pred Forte 58 hemoglobin A1c levels 58 mcg QD 58 #.#mmHg 58 LANTUS R 58 tirofiban 58 tobramycin inhalation solution 58 nadroparin 58 Acetate Rectal Suppositories 58 mmol L 58 CrCl 58 min -1 58 4mg/kg 58 Fasting plasma glucose 58 g dl 57 #.#-#.# p = 57 -#.# mmHg 57 fasting plasma glucose FPG 57 baseline serum creatinine 57 budesonide pMDI 57 serum triglycerides 57 glycated hemoglobin 57 triacylglycerol concentrations 57 plasma homocysteine 57 per deciliter mg 57 hip BMD 57 lispro alone 57 diastolic BP 57 ritonavir boosted 57 HbA1C levels 57 irbesartan 57 0mg 57 mU liter 57 aspartate aminotransferase AST 57 Hazard Ratio 57 mean baseline A1C 57 HDL Cholesterol 57 -#.# p = 57 mEq L 57 Plasma concentrations 57 #mg/day [002] 57 μg liter 57 plus GP IIb 57 leukocyte counts 57 CI #.#-#.# [002] 57 SGPT 57 OGTT 57 isoprostane 57 urine albumin 57 isoenzyme 57 BENICAR 57 % CI #.#-#.# [003] 57 glycosylated hemoglobin HbA1c 57 p = .# [001] 57 mmol kg 57 triglyceride TG 57 Â ± 57 3mg 57 x ULN 57 μg L 57 serum CRP 57 urinary albumin 57 -#.# USD JPY [002] 57 #mmHg [001] 57 PEG IFN 57 Hazard Ratio HR 57 HBeAg negative patients 57 sitosterol 57 % CI #.#-#.# [001] 57 oxycodone IR 57 mg kg ip 56 mU 56 uL 56 mmHg systolic 56 leuprorelin 56 + PH# 56 pg ml 56 F FLT 56 rFSH 56 transaminase 56 PREZISTA r arm 56 CR nPR 56 subcutaneous insulin 56 Double Blind Randomized 56 SGOT 56 achieved statistical significance 56 tHcy 56 #-# mg dL 56 ABC/3TC 56 EC naproxen 56 mm Hg systolic 56 hemoglobin Hb 56 IIIa inhibitors 56 titrated glipizide plus 56 Apidra ® 56 mU L 56 bivalirudin monotherapy 56 tipranavir r 56 estimated GFR 56 iPTH 56 tertile 56 ng dl 56 % CI #.#-#.# [008] 56 eplerenone 56 mean baseline HbA1c 56 mg tid 56 mg BID dose 56 racemic albuterol 56 hours postdose 56 pg mL 56 ml min 56 TAXUS p value 56 Lantus ® 56 Hazard Ratio = 56 QTcF 56 oxycodone CR 56 triglycerides TG 56 P = .# 56 atazanavir ritonavir 56 total cholesterol triglycerides 56 CI #.#-#.# [001] 56 cholesterol LDL C 56 MBq 56 nmol 56 interleukin IL -6 56 Hemoglobin A1c 56 antitrypsin 56 rho = 56 postop 56 intima media thickness 56 Serum creatinine 56 diuretic chlorthalidone 56 aOR 56 adenoma recurrence 55 statin monotherapy 55 HDL LDL 55 albumin excretion rate 55 salmeterol fluticasone propionate 55 #-#,# mg 55 #ug [001] 55 clodronate 55 ‰ ¥ 55 BRFS 55 #/#mmHg 55 mol L 55 hydroxyethyl 55 statistical significance p 55 comparator arm 55 systolic BP 55 pulmonary arterial 55 serum urate levels 55 noninferior 55 #mg doses [002] 55 cells uL 55 glucose insulin 55 p = ns 55 angiotensin converting enzyme 55 Insulin Glargine 55 % CI #.#-#.# [004] 55 dose atorvastatin 55 glycosylated hemoglobin 55 placebo p 55 serum homocysteine 55 benazepril 55 nitroprusside 55 FDA defined valvulopathy 55 -5 -6 55 Alanine 55 mg ustekinumab 55 LS BMD 55 fructosamine 55 Posaconazole 55 intact parathyroid hormone 55 pmol L 55 #.#,#.# [002] 55 Stent p = 55 glycated hemoglobin HbA1c 55 mmHg p 55 sUA levels 55 #ng/ml 55 serum triglyceride levels 55 heterozygotes 55 serum TSH 55 % CI #.#-#.# [007] 55 Score DAS# 55 Median PFS 55 nicardipine 55 â ‰ ¥ 55 ezetimibe simvastatin 55 H2RAs 55 carotid intima media 55 mcg kg min 55 #mg/day [001] 55 serum cortisol 55 biochemical relapse 55 posttreatment 55 #mm Hg 55 PANSS total 55 lopinavir r 55 PREZISTA ritonavir 55 severe NCI Grades 55 timolol 55 alanine transaminase 55 BMS p = 55 serum concentrations 55 hemoglobin A1C 54 μg g 54 #.#-#.# [002] 54 serum uric acid 54 rimonabant #mg 54 #mmHg [002] 54 nmol l 54 calculated creatinine clearance 54 Rating Scale BPRS 54 plasma glucose levels 54 mH 54 paricalcitol 54 FLOMAX 54 PRADAXA #mg 54 TIMP 1 54 3mg/kg 54 #ug [002] 54 calcium Ca 54 colorectal adenoma 54 microgram kg 54 mmHg 54 serum creatinine levels 54 -#.# log# copies mL 54 postprandial glucose PPG 54 Montgomery Åsberg Depression 54 LDL triglycerides 54 postprandial blood glucose 54 diastolic blood pressures 54 mEq L. 54 NovoLog ® Mix 54 binary restenosis 54 deoxy D 54 LEXIVA r 54 Serum concentrations 54 ULORIC 54 mL/min/#.# m2 54 postintervention 54 #.#g/day 54 linoleic acid LA 54 AUCs 54 NNT = 54 specific alkaline phosphatase 54 Fasting blood glucose 54 plus medroxyprogesterone acetate 54 μmol 54 TMC# r 54 mL sec 54 6mg 54 fluticasone propionate FP 54 DOWNSIDE MOVERS 54 homozygotes 54 platelet aggregation IPA 54 β = 54 mcg mL 54 Lovaza ® 54 8mg/kg 54 #.#/#.# mm Hg [001] 54 Diastolic pressure 54 #mg/dl 54 dehydroepiandrosterone sulfate 54 Betaferon R 54 Ishak fibrosis score 54 Lantus R 54 = #.#-#.# 54 MMSE score 54 IFN beta 54 REYATAZ r arm 54 η 54 CI #.#-#.# p = 54 baseline Hb 54 bronchioloalveolar carcinoma 54 dalteparin 54 flutamide 54 urate lowering therapy 54 μg m 54 5-FU/LV 54 lymphocyte count 54 t# c# CLA 54 corrected QT interval 54 confidence interval CI 54 #Gy 54 mcg BID 54 ALT elevations 54 1mg 54 HCTZ 54 cilostazol 54 HbA1c 54 moderate renal impairment 54 #.#mg/kg [002] 54 Lucentis monotherapy 54 PSA nadir 54 KOOS 53 ziprasidone 53 g cm 53 plasma leptin 53 ω 53 bioavailable testosterone 53 interleukin IL 53 SGRQ 53 mcg kg 53 doxazosin 53 amoxicillin clavulanate 53 stomatitis pharyngitis 53 IDDM 53 salmeterol fluticasone 53 serum HBV DNA 53 serum phosphorus 53 mg d 53 postprandial glucose 53 BMI z 53 serum PSA 53 adjunctive ABILIFY 53 β blockers 53 multivariable adjusted 53 #mg BID [001] 53 % CI #.#-#.# [006] 53 nadolol 53 AST ALT 53 Triglyceride levels 53 caspofungin 53 Brief Psychiatric 53 malondialdehyde MDA 53 preoperative PSA 53 complete cytogenetic response 53 glargine 53 #.#-#.# [011] 53 glycemia 53 mg/# hours 53 ischemia driven 53 morphometric vertebral fractures 53 NovoMix ® 53 plasma lipids 53 adefovir treated 53 serum ALT 53 Mg Usa 53 #mg dose [002] 53 interquartile range 53 pimecrolimus cream 53 Operative mortality 53 mu g 53 LDL HDL 53 mCi 53 -# mg dL 53 Low density lipoprotein 53 #μg [002] 53 COZAAR 53 insulin glulisine 53 +3 bps 53 endometrial thickness 53 QIDS SR 53 ADAS cog 53 #mg/kg [002] 53 anaplastic astrocytomas 53 plasma glucose 53 mg Androxal 53 p = #.# [003] 53 mm Hg diastolic 53 PROCTOCORT ® Suppository Hydrocortisone 53 desvenlafaxine succinate 53 pT3 53 normotensive 53 glomerular filtration rate 53 UACR 53 Sulfonylurea 53 Mg Uk 53 nmol L. 53 tPSA 53 trimethoprim sulfamethoxazole 53 ® fluocinonide Cream 53 PCWP 53 Glucophage metformin 53 Cilostazol 53 serum IgG 53 liver histology 53 #.#/#.# mm Hg [002] 53 Tipranavir 53 highest tertile 53 Vildagliptin 53 serum phosphorous 53 mg Proellex 53 -1 -2 53 preintervention 53 IPSS 53 carotid IMT 53 RLAI 53 DAS# CRP 53 MICARDIS 53 mCi kg 53 μg ml 53 acarbose 53 T2 lesion volume 53 experienced virologic failure 53 bronchoalveolar lavage 53 DAS# [002] 53 phosphate dehydrogenase 53 mso footer margin 53 urinary N telopeptide 53 lactate dehydrogenase LDH 53 VLDL cholesterol 53 fasting glucose levels 53 HDL triglycerides 53 μg dose 53 plus glycoprotein IIb 53 pCR 53 mineral density 53 CIMZIA TM 53 -#.# [006] 53 ADCS ADL 53 nocturnal awakenings 53 Cream USP 1 53 pyridyl 53 umol L 53 plasminogen activator inhibitor 53 kg -1 53 hMG 53 plasma triglycerides 53 HBeAg 53 Flu Cy 53 ALT normalization 53 zoledronate 53 serum estradiol 53 tranylcypromine 53 #mg #mg #mg [003] 52 milliliter ng ml 52 nonsignificant difference 52 echocardiographic parameters 52 σ 52 conjugated equine estrogens 52 maternal serum 52 serum triglyceride 52 thrombosis embolism 52 Prospective Randomized Trial 52 Non Responders 52 LDL cholesterol LDL 52 BYSTOLIC 52 tertiles 52 ritonavir Norvir 52 amprenavir 52 ^ sup #m 52 sUA 52 PEY 52 nondiabetics 52 deoxyglucose 52 transaminases 52 ± #ppm [001] 52 urinary oxalate 52 mcg ml 52 monocyte chemotactic protein 52 REMICADE monotherapy 52 HDL cholesterol HDL 52 daunorubicin 52 NRTI sparing 52 Mg Li 52 undetectable viral 52 Score IPSS 52 olmesartan medoxomil hydrochlorothiazide 52 oral antidiabetic medication 52 = .# 52 PUFA intake 52 neuropathy sensory 52 ApoB 52 Consensus +#.# 52 Hcy 52 ng dL 52 #.#ng/ml 52 mIU L 52 eosinophil count 52 IRLS score 52 Hydrochloride Injection 52 creatine phosphokinase 52 periprocedural 52 Intraocular pressure 52 dapagliflozin plus 52 titrated glipizide 52 PANSS scores 52 spine BMD 52 IFN α 52 Diastolic 52 hypophosphatemia 52 Nebulized 52 pulmonary capillary wedge 52 serum ferritin 52 metoprolol tartrate 52 efavirenz EFV 52 gm dl 52 NTx 52 LV dysfunction 52 cells mcL 52 Pearson correlation coefficient 52 collagenous colitis 52 Tf 52 certolizumab 52 urinary excretion 52 somatostatin analog 52 glycaemia 52 idraparinux 52 Thyroxine 52 +2 bps 52 Partial Response 52 glutamyl 52 invasive carcinomas 52 mg XP# 52 oxyhemoglobin 52 Crohn Disease Activity 52 TNFalpha 52 serum phosphate levels 52 CDAI score 52 nitrotyrosine 52 Kd2 52 % miconazole nitrate 52 plasma renin 52 fasting triglyceride levels 52 mg m² 52 BUPHENYL R sodium phenylbutyrate 52 serum lipid 52 trough FEV1 52 vitamin D metabolite 52 triacylglycerol 52 subcutaneous enoxaparin 52 oral antidiabetes 52 abdominal circumference 52 fosamprenavir 52 LDL cholesterol HDL cholesterol 52 ob ob mice 52 logMAR 52 elevated creatinine 52 log# reduction 52 N acetyl 52 cyclophosphamide methotrexate 52 serum sodium 52 ergocalciferol 52 neutrophil counts 52 IOP lowering 52 LOVENOX 52 pmol liter 52 Benzoyl Peroxide 52 colony stimulating factor 52 tapentadol ER 52 mol 52 unboosted 52 Viread Emtriva Sustiva 52 YMRS 52 CYP#A# [002] 52 IFN alfa 52 log# 52 total cholesterol LDL 52 troponin T 52 hydroxypropyl 52 quetiapine risperidone 52 EMRG VIO 52 cTnI 52 muscarinic 52 lamotrigine 52 LV ejection fraction 52 adrenergic receptors 52 pooled comparator 52 kcal d 52 Peg IFN 52 achieved ACR# 52 hepatic insulin sensitivity 52 Visual Analogue Scale VAS 52 nonobese 52 FLEXERIL 52 ACTEMRA TM 52 -#.# mm Hg 52 #.#mg [002] 52 Darusentan 52 serum phosphate 52 Aggrenox R 52 sirolimus stent 52 fasting serum 52 #.#-#.# [005] 52 mg hydrochlorothiazide 52 pmol 52 thyroxine 52 segment binary restenosis 52 jrw 52 arterial oxygen saturation 52 ± SD 52 mg QD 52 DAS# remission 52 nanograms milliliter 52 CsA 52 casein hydrolyzate 52 PASI scores 52 multivariate adjusted 52 rh 52 #S #S [003] 52 chlorambucil 52 Cypher Stent 52 XIENCE V PROMUS Stent 52 matrix metalloproteinase MMP 52 mg p = 52 t# c# 52 glomerular filtration 52 g dietary fiber 52 ρ 52 Rating Scale MADRS 51 plus dexamethasone 51 umbilical artery 51 ARB telmisartan 51 serum calcium levels 51 SPIRIVA ® 51 IU mL 51 urinary sodium excretion 51 Peginterferon Alfa 2a 51 atheroma volume 51 ADAS Cog 51 Prostaglandin 51 carotid artery thickness 51 CK MB 51 confidence intervals CIs 51 macroalbuminuria 51 creatinine clearance 51 candesartan cilexetil 51 systolic blood pressures 51 olmesartan 51 hypogonadal 51 #.# ASIA ADRS [001] 51 Lumbar spine 51 AUA Symptom Score 51 glyburide 51 ± 51 chlorthalidone 51 #mg #mg [001] 51 gadolinium enhancing 51 follicular phase 51 Tenormin 51 lipid parameters 51 #mg/dL [001] 51 antibody titer 51 vitamin D intakes 51 statistically significant p = 51 fasting insulin 51 glucuronide 51 A1C levels 51 multivariable analysis 51 prednisone prednisolone plus 51 serum IGF 51 thiazide diuretics 51 sd = 51 FOLFOX4 alone 51 ,8 51 tamsulosin 51 WOMAC pain 51 fluticasone furoate 51 #.# +#.# +#.# [009] 51 euthyroid 51 DAPT 51 Alzheimer Disease Assessment 51 blood Phe 51 lactate dehydrogenase 51 epoetin beta 51 c9 t# 51 #mg BID [003] 51 homocysteine concentrations 51 advanced adenoma 51 cm -3 51 Pfizer Norvasc 51 atazanavir Reyataz 51 Ramipril 51 fasting blood glucose 51 adenoma detection 51 detrusor 51 Si#DB 51 Trandolapril 51 methotrexate monotherapy 51 ECOG PS 51 Left Ventricular Ejection Fraction 51 beta 1a 51 μg 51 serum phosphorus levels 51 pretest probability 51 receiving ISENTRESS 51 primary hypercholesterolemia 51 Tmax 51 nonfasting triglyceride levels 51 phosphodiesterase PDE 51 ANCOVA 51 triglyceride concentrations 51 hypogonadal men 51 nonfasting 51 hypertensives 51 creatinine levels 51 #.# #.# -#.# [002] 51 biopsy Gleason 51 ug mL 51 NMIBC 51 overt nephropathy 51 HDL2 51 International Prostate Symptom 51 Eq. 51 refractory ischemia 51 tolterodine ER 51 clinically meaningful reductions 51 CR CRu 51 gastric pH 51 serum glucose 51 logistic regression analysis 51 interleukin IL -# 51 stavudine d4T 51 regulated kinase 51 osmolality 51 RYGB 51 NIHSS 51 adiponectin concentrations 51 X ULN 51 Pain Intensity 51 Mg ha 51 ATACAND 51 cytokeratin 51 arterial thromboembolic events 51 carotid artery intima media 51 mg dl 51 Ultra Financials ProShares 51 QVAR R 51 POL PRO 51 metabolizing enzyme 51 Montgomery Asberg Depression 51 placebo Hazard Ratio 51 piperacillin tazobactam 51 NIH CPSI 51 Engerix B 51 RU EUROPE ASIA EEU 51 salivary cortisol 51 twd ccg 51 vildagliptin 51 8mg 51 ß blockers 51 +#.# Yuan 51 mg dL 51 serum testosterone 51 Degludec 51 insulin glargine 51 normal ULN 51 t4 51 N telopeptide 51 GPIIb IIIa inhibitors 51 HDL cholesterol concentrations 51 postprandial glycemia 51 insulin aspart 51 hydroxymethyl coenzyme 51 3g fiber 51 g trans fats 51 cell adhesion molecule 51 g carbo 51 Interferon gamma 51 CC genotype 51 mm3 51 triacylglycerols 51 chemoradiation therapy 51 cholesterol LDL cholesterol 51 nonfatal MI 51 osteopenic 51 CK # plasma concentrations 51 rs# [001] 51 leucopenia 51 neutrophil count 51 QbG# 51 kappa = 51 8 OHdG 51 luminal diameter 51 ß carotene 51 Cholinesterase Inhibitors 51 nmol L 51 leukotriene B4 51 μg doses 51 UPDRS 51 SOIR readings 51 coronary stenosis 51 umol 51 serum calcium 51 μg dL 51 UPDRS motor 51 statistically significant p 51 non splenectomized 51 metastatic malignant 51 MADRS 51 SBP DBP 51 insulin degludec 51 undetectable HBV DNA 51 serum insulin 51 kg/m2 51 #.#mg [001] 51 intramuscular dose 51 % #NY.INST 51 urinary calcium 51 ACE inhibitor benazepril 51 #.#mg/kg [001] 51 dehydrogenase 51 leukopenia 50 urinary albumin excretion 50 lipid lowering agents 50 dose dependently 50 thickness CIMT 50 Ejection Fraction 50 μmol l 50 fractional shortening 50 lanthanum carbonate 50 elevated troponin 50 baseline A1C 50 MCXCOMDEX trades 50 eNO 50 T2DM 50 fraction LVEF 50 thyroglobulin 50 normothermic 50 UNCH 50 Demonstrated Significant 50 atherogenic 50 monicca.egoy @ thomson.com mbe 50 glycosylated hemoglobin levels 50 NeoRecormon 50 Î ¼ 50 FOLFOX6 50 Lipitor #mg 50 #.#-# [029] 50 advanced adenomas 50 GlaxoSmithKline Requip 50 macrophage inflammatory protein 50 primary patency 50 SUVmax 50 inhibin 50 Insulin PH# 50 timepoints 50 receptor blocker 50 Hb A1c 50 IELT 50 subscore 50 simvastatin #mg 50 metformin sulphonylurea 50 = -#.# 50 mg kg dose 50 Ondansetron Injection USP 50 transdermal estradiol 50 hematological parameters 50 p = #.# [004] 50 HMG CoA reductase inhibitor 50 potassium supplementation 50 ribavirin RBV 50 diameter stenosis 50 vitreous haze 50 Ag g tx 50 CYT# QbG# 50 hs CRP 50 K + ATPase 50 mg/m2 dose 50 delivered subcutaneously 50 pretreatment baseline 50 serum lipid levels 50 p = 50 NovoMix 50 odds ratios ORs 50 Butyrate 50 MetroGel R 50 D dimer 50 acyltransferase 50 postprandial insulin 50 0g 50 recurrent venous thromboembolism 50 SVR# 50 α 50 lymphocytosis 50 unfractionated heparin 50 IBDQ 50 Fluticasone Propionate 50 Cabot CBT 50 receiving VICTRELIS 50 nanomolar 50 mg RDEA# 50 hydroxyproline 50 yttrium oxide 50 +#.# = RR 50 micrograms mL 50 cons. 50 6MWD 50 Scale cognitive subscale 50 TURBT 50 Angiotensin converting enzyme 50 systolic diastolic blood 50 paresthesias 50 annualized relapse 50 apnea hypopnea 50 ^ Tc 50 abciximab 50 TNF Tumor Necrosis Factor